Trials / Recruiting
RecruitingNCT05562960
Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Against NRIP
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- National Taiwan University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Patient with amyotrophic lateral sclerosis (ALS) having anti-NRIP autoantibody showed titer-dependent detrimental Effects. Plasmapheresis might benefit this subgroup of patients via removal of anti-NRIP autoantibody
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Plasmapheresis | Regular plasmapheresis to remove anti-NRIP autoantibody |
Timeline
- Start date
- 2023-05-01
- Primary completion
- 2025-03-31
- Completion
- 2025-03-31
- First posted
- 2022-10-03
- Last updated
- 2024-12-18
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05562960. Inclusion in this directory is not an endorsement.